Investigators will no longer be required to supply copies (paper packets) to the IRB office after the electronic submission has been given an IRB#. Investigators will be notified of the assigned IRB# by email. Applications for Full Board Review will be reviewed at the next possible IRB meeting. For details see the IRB Submission Process website.
We are starting a new focus group for brain and spine tumors where basic, translational, and clinical research will be discussed in formal and informal ways for the diagnosis and treatment of these tumors. This may include primary or secondary tumors. The overarching goal of this group is to strengthen our Comprehensive Cancer Center and ultimately improve patient care.
Our objectives are to:
1) Foster collaboration in neuro-oncology research
2) Compete for national funding for basic and translational research as well as clinical trials
Our monthly meeting will be held on the 2nd Monday of each month from 4-5PM. All interested investigators, cancer center members and their immediate colleagues (lab personnel and residents, etc.) are invited to attend. In this way, we hope to inspire new projects and collaborations.
The first meeting will be held on Monday July 8th, 2013 at 4PM in Neurosurgery conference room, UT 4124.
If you have any questions, please email Michele Aizenberg or Nicole Shonka.
Michele Aizenberg, M.D.
Nicole Shonka, M.D.
Surinder Batra, Ph.D.
Notice Number: NOT-HS-13-004
Release Date: December 10, 2012
Estimated Publication Date of Announcement: Late winter, 2013
First Estimated Application Due Date: Spring, 2013
Earliest Estimated Award Date: Summer, 2013
Earliest Estimated Start Date: Summer, 2013
Agency for Healthcare Research and Quality (AHRQ)
AHRQ intends to publish a Funding Opportunity Announcement (FOA) to broadly solicit applications for research centers to participate in the “Developing Evidence to Inform Decisions about Effectiveness” (DEcIDE) Network, a component of AHRQ’s Effective Health Care Program (see http://effectivehealthcare.ahrq.gov/). AHRQ plans to continue the collaborative research network that it established in 2005 with a specific focus on comparative effectiveness and patient-centered outcomes research (CER/PCOR) and methodologies that are designed to support evidence-base decision-making in patient communities served by (1) Medicare; or (2) State Medicaid and/or Children’s Health Insurance (CHIP) programs. Overall FOA objectives are to conduct original research and appropriately disseminate the results to stakeholders.